NASDAQ: NEPH - Nephros, Inc.

Доходность за полгода: +31.6%
Дивидендная доходность: 0.00%
Сектор: Healthcare

График акции Nephros, Inc.

Расширенный график Простой график
Financial Markets by TradingView

О компании Nephros, Inc.

Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.

подробнее
The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Добавить в список сравнения
Добавить в список отслеживания
Добавить в портфель
Добавить уведомление о цене

IPO date 2004-09-21
ISIN US6406714005
Industry Household Durables
Sector Consumer Discretionary
Валюта usd
Валюта отчета usd
Сайт https://www.nephros.com
Цена ао 1.6
Изменение цены за день: -0.0253% (1.9745)
Изменение цены за неделю: +5.56% (1.87)
Изменение цены за месяц: +22.49% (1.6115)
Изменение цены за 3 месяца: +23.38% (1.6)
Изменение цены за полгода: +31.6% (1.5)
Изменение цены за год: -0.804% (1.99)
Изменение цены за 3 года: -53.44% (4.24)
Изменение цены за 5 лет: -71.1% (6.83)
Изменение цены с начала года: +34.29% (1.47)
Все параметры

Недооценка

Название Значение Оценка
P/S 2.25 6
P/BV 3.84 4
P/E 0 0
EV/EBITDA -21.48 0
Итого: 3.5

Эффективность

Название Значение Оценка
ROA, % -13.28 0
ROE, % -18.84 0
Итого: 0

Дивиденды

Название Значение Оценка
Div yield, % 0 0
DSI 0 0
Итого: 0

Долг

Название Значение Оценка
Debt/EBITDA -1.33 10
Итого: 9.4

Импульс роста

Название Значение Оценка
Доходность Revenue, % 38.23 5
Доходность Ebitda, % -57.53 0
Доходность EPS, % -64.02 0
Итого: 1
Подробнее

Институционалы Объем Доля, %
Wexford Capital LP 3682724 48
Bard Associates Inc. 187318 2.44
Vanguard Group Inc 171310 2.23
Geode Capital Management, LLC 71037 0.93
HighTower Advisors, LLC 56710 0.74
Blair (William) & Company, L.L.C. 36249 0.47
Morgan Stanley 33774 0.44
Elkhorn Partners Limited Partnership 31900 0.42
State Street Corporation 15698 0.2
Mesirow Financial Investment Management, Inc. 15383 0.2



Руководитель Должность Оплата Год рождения
Mr. Robert Banks President, CEO & Director 474.04k 1975 (50 лет)
Ms. Judy F. Krandel C.F.A. Chief Financial Officer 147.01k 1965 (60 лет)
Brianne McGuire Director of Brand, Marketing & Business Development N/A
Vashone R. Thomas Vice President of Quality, Regulatory, & Human Resources N/A
Mr. Greg Lucas President of Aether Water Systems N/A
Ms. Judy Mazzini Controller N/A
Mr. Alfred Vargas Director of Operations N/A
Mr. Daron G. Evans M.B.A., M.S. Chief Executive Officer of Specialty Renal Products, Inc 300.18k 1974 (51 год)

Адрес: United States, South Orange. NJ, 380 Lackawanna Place - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.nephros.com